Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Change in Taxes (2016 - 2025)

Historic Change in Taxes for Myriad Genetics (MYGN) over the last 16 years, with Q3 2025 value amounting to -$500000.0.

  • Myriad Genetics' Change in Taxes rose 6153.85% to -$500000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.2 million, marking a year-over-year decrease of 70000.0%. This contributed to the annual value of -$500000.0 for FY2024, which is 2857.14% up from last year.
  • According to the latest figures from Q3 2025, Myriad Genetics' Change in Taxes is -$500000.0, which was up 6153.85% from -$2.1 million recorded in Q1 2025.
  • Myriad Genetics' Change in Taxes' 5-year high stood at $18.1 million during Q4 2021, with a 5-year trough of -$90.3 million in Q1 2021.
  • In the last 5 years, Myriad Genetics' Change in Taxes had a median value of -$400000.0 in 2023 and averaged -$5.9 million.
  • Examining YoY changes over the last 5 years, Myriad Genetics' Change in Taxes showed a top increase of 10202.43% in 2021 and a maximum decrease of 1300000.0% in 2021.
  • Quarter analysis of 5 years shows Myriad Genetics' Change in Taxes stood at $18.1 million in 2021, then tumbled by 101.1% to -$200000.0 in 2022, then tumbled by 150.0% to -$500000.0 in 2023, then decreased by 20.0% to -$600000.0 in 2024, then increased by 16.67% to -$500000.0 in 2025.
  • Its last three reported values are -$500000.0 in Q3 2025, -$2.1 million for Q1 2025, and -$600000.0 during Q4 2024.